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Abstract
The function of the nuclear receptor Rev-erba (Nr1d1) in the brain is, apart from its role in the circadian clock mechanism,
unknown. Therefore, we compared gene expression profiles in the brain between wild-type and Rev-erba knock-out (KO)
animals. We identified fatty acid binding protein 7 (Fabp7, Blbp) as a direct target of repression by REV-ERBa. Loss of Rev-
erba manifested in memory and mood related behavioral phenotypes and led to overexpression of Fabp7 in various brain
areas including the subgranular zone (SGZ) of the hippocampus, where neuronal progenitor cells (NPCs) can initiate adult
neurogenesis. We found increased proliferation of hippocampal neurons and loss of its diurnal pattern in Rev-erba KO mice.
In vitro, proliferation and migration of glioblastoma cells were affected by manipulating either Fabp7 expression or REV-
ERBa activity. These results suggest an important role of Rev-erba and Fabp7 in adult neurogenesis, which may open new
avenues for treatment of gliomas as well as neurological diseases such as depression and Alzheimer.
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Introduction
In mammals the circadian clock system regulates many aspects
of systemic biology such as biochemistry, physiology and behavior
with the suprachiasmatic nuclei (SCN) as the main coordinating
entity to synchronize all cellular clocks in the body. At the cellular
level, the circadian clockwork consists of interwoven positive and
negative feedback loops, or ‘limbs’. The positive limb involves
BMAL1/CLOCK heterodimers that bind to E-boxes located in
the regulatory region of the period (Per) and cryptochrome (Cry) genes.
CRY and PER proteins form oligomers that are transported from
the cytoplasm to the nucleus, where they repress their own
transcription by inhibiting BMAL1/CLOCK (negative limb). The
positive and negative limbs are further interlaced as BMAL1/
CLOCK also induces the expression of the nuclear receptor REV-
ERBa (NR1D1), which represses the transcription of Bmal1 via
direct binding to a REV-ERBa response element (RORE) in the
Bmal1 promoter [1]. In addition to its action in the circadian clock
mechanism, REV-ERBa also has strong regulatory functions in
liver metabolism [2,3] and drugs targeting it may have potential
applications for treatment of metabolic syndrome [4]. However,
the roles of REV-ERBa in the central nervous system remain
unclear.
Components of the clock mechanism modulate neurogenesis.
For example Per2 regulates neural stem/progenitor cell prolifer-
ation in the adult hippocampus [5] while Bmal1/Clock seems to
regulate neurogenic transcription factors such as Neuro D1 and
differentiation of neuronal stem/progenitor cells in the subven-
tricular zone (SVZ) of the lateral ventricle [6]. Furthermore, gene
expression profiling revealed an increased expression of Rev-erba in
neural progenitor cells (NPCs) compared to immature neurons [7].
Outside of the central nervous system, in the skin, the clock
appears to play a role in the regulation of stem cell differentiation
[8,9].
Adult neurogenesis is an important process, because it may
replace lost or dysfunctional cells by generating new neurons via
neural stem cells (NSCs) [10]. A dysfunction of this process may
lead to neuropsychiatric diseases such as age-related cognitive
decline [11] and depression (reviewed in [12]). Substantial
generation of new neurons occurs mainly in two brain areas: the
subventricular zone (SVZ) lining the lateral ventricles [13] and the
subgranular zone (SGZ) of the hippocampal dentate gyrus (DG)
[14]. Adult hippocampal neurogenesis in mammals is a sensitive
process, which is affected by environmental stimuli, such as stress
[15,16], physical activity [17], sleep deprivation [18], enriched
living conditions [19], and jet-lag [20,21]. Such environmental
changes directly affect the circadian clock [22], suggesting that the
clock may be a mediator between environmental change and
neurogenesis. This hypothesis is supported by the observation that
neurogenesis fluctuates over the day [23–26] indicating that the
circadian clock or components of it may influence neurogenesis.
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Since REV-ERBa is strongly expressed in the brain [27] and in
NPCs [7] we performed genome wide expression profiling in the
SCN of wild-type and Rev-erba KO mice. We found fatty acid
binding protein 7 (FABP7), also termed brain lipid binding protein
(BLBP), to be strongly up-regulated in Rev-erba KO animals.
FABP7 is a family member of the fatty acid binding protein family,
which facilitates the solubility of hydrophobic long chain fatty
acids. They function primarily in fatty acid uptake/transport [28],
and have been widely implicated in cell growth and differentiation
[29]. FABP7 is a well-known marker for NPCs [30] in neurogenic
niches of the hippocampal SGZ [31] and in the forebrain SVZ
[32]. It is expressed in type 2 and 3 NSCs and early transitory
amplifying cells (TAPs) but not in late TAPs and neuroblasts [32].
Interestingly, Fabp7 mRNA is expressed in a time of day
dependent manner in hippocampal granule precursors in adult
mice [33] and its localization and grade of polyadenylation are
diurnal [34]. These observations implicate an involvement of
circadian clock components in the regulation of Fabp7 and adult
neurogenesis.
In this study we show that Fabp7 is a direct target gene of Rev-
erba and that both genes are involved in aspects of adult
neurogenesis in mice.
Methods
Animal experiments
Animal handling and care was performed in accordance with
the guidelines of the Schweizer Tierschutzgesetz (TSchG, SR455)
and the declaration of Helsinki. The protocol was approved by the
state veterinarian of the Canton of Fribourg. Suffering of animals
was minimized by anesthesia that was induced at 4.5 to 5%
isoflurane and lowered to 2–1.5% isoflurane mixed with oxygen
(0.8l/min). Rev-erba2/2 knockout mice [27] were obtained from
heterozygous Rev-erba breeding pairs originally provided by Prof.
U. Schibler, Geneva. Two to four month old animals were used
for experiments and wild-type mice served as controls. Animals
were kept under 12 h light and 12 h dark (LD 12:12) with food
and water ad libitum.
Cell culture
NG 108-15, mouse neuroblastoma x rat glioblastoma cells [35]
and U-251 MG, human malignant glioblastoma tumour [36] were
used for in vitro experiments. Cells were maintained in Dulbecco’s
Modified Eagle Medium (DMEM), high glucose [4.5 g/l](Sigma
6429) containing 10% fetal calf serum (FCS) and 100 U/ml
penicillin/streptomycin at 37uC in a humidified atmosphere
containing 5% CO2. Sub-confluent cultures were split 1:3 to 1:6.
Affymetrix oligonucleotide microarray hybridization
To obtain sufficient amounts of SCN, tissue of 18 male mice (3
months) were used per genotype. Dissection was performed at time
point ZT 14. SCN of 6 animals were pooled to yield 3 samples of
wild-type and Rev-erba2/2 mice each, and homogenized in RNA-
Bee (AMS Biotechnology) using syringe and needle (Ø 0.19 mm).
RNA extraction was performed with chloroform, followed by
isorpropanol precipitation and wash with EtOH. For further
purification RNA was precipitated again with 0.4 M NaOAc/
0.2% SDS and extracted using phenol:chloroform:isoamylalcohol.
RNA quality and integrity was checked by absorbance ratio A260/
A280, on denaturing agarose gels and by using the Agilent 2100
Bioanalyzer. 5 mg of total RNA were employed for the synthesis of
biotinylated cRNA and 17.5 mg of this cRNA were hybridized to
Affymetrix Mouse Genome 430 2.0 array (according to the
Affymetrix protocol). The signal intensities were analyzed using
Partek Genomics suites (Partek, St. Louis, MI, USA) and Matlab
(The MathWorks Inc., Natick, Massachusetts, USA) The data
were normalized using RMA [37]. The selections were based on
the fold-change intensities and p values (p,0.05). Genes for which
the concordance in the pairwise comparisons exceeded the
imposed threshold of 77% (seven out of nine comparisons) were
considered as statistically significant and only transcripts whose
accumulation had an average change of at least 1.5-fold were
extracted (Tables S1 and S2).
In situ hybridization
The in situ hybridization probe for mFabp7 was cloned from
cDNA corresponding to nucleotides 34–588 (accession number:
NM_021272). Primer used for pCR II TOPO (Invitrogen) cloning
are displayed in Table S1. Specimen preparation, 35S-rUTP
labeled riboprobe synthesis and hybridization steps were per-
formed as described earlier [38]. Quantification was performed by
densitometric analysis of autoradiograph films (Amersham Hy-
perfilm MP) using the Quantity One 1-D analysis software
(Biorad). Data from the region of interest was normalized by
comparison with the signal intensities in an equal area of the
lateral hypothalamus. Relative mRNA abundance was calculated
by defining the maximal value of each experiment as 100%. Slides
were further analyzed by dipping in NTB-2 emulsion and
microscopy (Zeiss Axioplan 2). Silver grains were visualized with
dark field illumination and tissue was visualized by counterstaining
of nuclei with Hoechst-dye.
Luciferase reporter assays and transfection
A 1.4 kb fragment of the mouse Fabp7 promoter region
(nucleotides -19348 to the transcriptional start site, containing
RORE at 2934 and 2257) was cloned into the pGL3 basic vector
(Promega) using the primers indicated in Table S1. Deletion of the
proximal RORE (nucleotide 2257) was achieved by site directed
mutagenesis using primers displayed in Table S1, which led to
replacement of the proximal RORE (TGACCT) by nucleotides
GATATC. Expression vectors for Rev-erba (NM_145434) and Rora
(NM_013646) have been described [39] and an expression vector
for b-galactosidase was used as control. Transfection and luciferase
reporter assays were performed with NG108-15 cells (Neuroblas-
toma) according to [40]. Empty pGL3-vector and Bmal1 promoter
region cloned into pGL3 [39], were used as negative and positive
controls, respectively. Real-time bioluminescence was monitored
as described in [39] using a LumiCycle apparatus (Actimetrics).
Chromatin immunoprecipitation (ChIP)
Hippocampal tissue was dissected using a mouse brain slicer
(Zivic instruments). Freshly isolated tissue of two animals was
combined for homogenization in 1% formaldehyde/1xPBS
pH 7.4 and cross-linked for 5 min at RT. Nuclei and soluble
chromatin fragments were obtained by ultracentrifugation through
1.8 M sucrose cushions and sonication according to [41].
Chromatin was precipitated with antibodies raised against REV-
ERBa [42] and co-immunoprecipitated DNA was quantified with
TaqMan real-time PCR using the primers and probes described in
Table S1. ChIP data was normalized against corresponding input
data and results were presented as percent of input.
Quantitative Real-time PCR (qRT-PCR)
Total RNA was extracted and purified from snap frozen brain
tissue using RNeasy kit (Qiagen) with on column DNAse digestion.
RNA from cultured cells was extracted using RNA-Bee (AMS
Biotechnology), purified by phenol:chloroform extraction and
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ethanol precipitation. cDNA was synthesized with SuperScript II
(Invitrogen) and random priming. SYBR green fluorescence-based
real-time PCR was performed for RNA quantification (KAPA
SYBR FAST Universal, KAPA Biosystems, RotorGene 6000,
Corbett Research). All RNA samples were normalized to Gapdh.
Primers are listed in Table S3.
Western blot analysis
Using RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl,
1 mM EDTA, 0.1% SDS, 1% Triton X-100, 0.5% sodium
deoxycholate containing protease and phosphatase inhibitors),
protein of cultured cells and brain tissue was extracted. Proteins
were separated on 12.5% SDS-PAGE and transferred to
nitrocellulose (Protran BA 83, 0.2 mm pores, GE healthcare).
Primary antibodies were incubated over night at 4uC, Anti-rabbit
FABP7 1:250 (Abcam ab27171), Anti-rabbit actin 1:5000 (Sigma,
A5060) and Anti-BMAL1 1:1000 [42]. Detection of the immune
complexes was performed using Western Bright Quantum system
(Advansta) and quantification was done with the Quantity One
analysis software (BioRad). Actin was used for normalization and
relative protein levels were calculated by defining maximal protein
levels as 1.
Behavioral studies
Porsolt Forced swim tests were performed using a cylindrical tank
(35 cm height, 25 cm diameter) filled with water to a height of
20 cm. The water temperature was maintained at 2762uC. An
initial period of 2 min was given for habituation, then immobility
time was recorded during 4 min using a stopwatch. Mice were
considered immobile, when no obvious limb movements were
observed and the floating body did not move actively through the
water. After a total session of 6 min, mice were warmed up on a
heating pad, and then placed back into their home cage. Mice
were tested the same time of day (ZT 6 and ZT 18) at three
subsequent days and mean values were plotted as cumulative
immobility time in seconds.
For Tail suspension tests mice were suspended individually from
the tail, fixed to a cord hanging in a box (36.5 cm high,
30.5630.5 cm2) (according to the EMPRESS standard operating
procedure http://empress.har.mrc.ac.uk). Animals were judged to
be immobile when not agitating and not attempting to escape.
Immobility was recorded during 6 min with a stopwatch. Tests
were repeated for three subsequent days at the same time point
(ZT 6 and ZT 18) and mean values were plotted as cumulative
immobility time in seconds.
Prepulse inhibition (PPI) tests were carried out with acoustic stimuli.
Mice were tested in a startle chamber (SR-lab System, San Diego
instruments) positioned within a sound-proof cabinet in a sound-
attenuating room according to standard methodology [43]. A
constant background white noise of 64 dB was presented
throughout the test. To measure prepulse inhibition, mice were
presented with a 68, 72, 76, 80 and 84 dB prepulse (for 20 ms)
followed by a 120 dB pulse (for 40 ms in length) 100 ms later. The
percentage PPI of the startle response was calculated using the
following formula: 100-[(SRPP/SR)x100]. SR denotes the startle
response to the pulse stimulus, whereas SRPP denotes the startle
response to the pulse with prepulse stimulus.
Elevated O-maze test was used to test anxiety, which affects mood-
related behaviors. The relationship between curiosity/exploration
and fear/hiding in a protected area is investigated. The elevated
O-maze consisted of an elevated (42 cm above the floor) annular
runway (outer diameter was 46 cm with 5.5 cm in with) divided
into 4 sectors. The two 90u closed sectors were protected by 11 cm
high inner and outer walls, while the remaining two open sectors
were unprotected. Animals were released at the interface of the
closed and open area and recorded for 5 min using a video
camera. Number of entries and time spent in the open sector were
counted. In order to avoid habituation to the maze, mice were
tested once for a total session of 5 min.
Y-maze spontaneous alternations test was performed to test the
working memory of mice using a Y-shaped maze with three plastic
arms (height: 12.7 length: 38.3, width: 7.6 cm) at 120u angles.
After introduction in the middle of the maze, mice were allowed to
freely explore the three arms for 5 minutes. Sessions were
videotaped and the sequential entries into each arm (A, B, C) were
noted. An arm entry was scored when all four limbs of the animal
were within an arm. Each set of three consecutive choices where
no repeated entries occurred (counting also overlapping triplets)
was scored as alternation. The Y-maze score was calculated as
follows [number of alternations/(number of total entries-2)*100], a
Y-maze score of 50% indicates random selection of arm entries.
The maze was cleaned with 70% ethanol after each test. Tests
were performed during the resting phase of mice between ZT 4 to
ZT 6.
Spatial object recognition (SOR) tasks were performed in an
arena (30630630 cm) with two objects, a plastic square
(6.562.568.5 cm) and a metal cylinder (h: 9 cm, r: 2.2 cm). The
bottom plate of the arena was decorated on one side with black
and white stripes as a spatial cue. Mice were habituated to the
empty arena for 10 min, subsequently the arena was cleaned with
70% ethanol and two objects were placed in the arena at opposite
corners (upper left and lower right). The mice were introduced in
the center of the arena and allowed to explore the arena for
10 min (object training). Object training was repeated on three
consecutive days (24-h intervals) for 10 min each. Twenty-four
hours after the third training one object was displaced to a new
location (displaced object, DO) while the other object was not
moved (non-displaced object, NOD) and the mice were allowed to
explore the new situation during 10 min. The identity of the DO
(plastic square or metal cylinder) was balanced between groups.
The third training session and test session were videotaped. The
response to spatial change was assessed by calculating the
percentage of time spent exploring the DO vs. NOD. Exploration
was scored when mice were facing and sniffing the objects within
very close proximity and/or touching them.
Immunohistochemistry
Animals used for immunohistochemistry were sacrificed at ZT
6. Perfused brains were cryoprotected and sectioned (40 mm,
coronal) using a cryostat. Sections chosen for staining were placed
in 24-well plates (up to 4 sections of one sample per well), washed 3
times in 1xTBS and twice in 2xSSC pH 7.0 (0.3 M NaCl/0.03 M
tri-Na-citrate). Antigen retrieval was performed with 50%
formamide/26SSC by heating to 65uC for 50 min. Then, sections
were washed twice in 2xSSC and 3 times in 1xTBS pH 7.5 (0.1 M
Tris/0.15 M NaCl), before blocking them for 1 h in 10% fetal
bovine serum (FBS)/0.1% Triton X-100/1xTBS at room
temperature (RT). Directly after the blocking step, primary
antibodies (DCX [Santa Cruz, SC8066], NeuN [Millipore,
MAB377], FABP7 [abcam ab27171]) diluted in 1% FBS/0.1%
Triton X-100/1xTBS were added to the sections and incubated
overnight at 4uC. The next day sections were washed 3 times in
1xTBS and incubated with the appropriate fluorescent secondary
antibodies diluted 1:500 in 1% FBS/0.1% Triton X-100/16TBS
for 3 h at RT (Dk-Anti-mouse Cy5 [715-605-150], Dk-Anti-rabbit
Cy2 [711-545-152], Dk-Anti-rabbit Cy3 [711-165-152], Dk-Anti-
goat Cy3 [705-165-147], all from Jackson Immuno Research).
After 3 washes with 1xTBS, nuclei were counterstained with DAPI
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for 10 min. Finally the tissue sections were washed again twice in
1xTBS and mounted on glass microscope slides. Slides were stored
horizontally for at least one day at 4uC to allow the mounting
medium to solidify. Fluorescent images were taken by using a
confocal microscope (Leica TCS SP5), equipped with objectives
10x, 20x, and 40x, and an inverted DMI6000 stand with
motorized stage. Images were taken with a resolution of
102461024, scan speed 400 Hz and Z-stack of 1.5 mm through
the whole section with frame average 3. Images were processed
with LAS AS software from LEICA.
Assessment of cell proliferation and neurogenesis
Mice aged 6–12 weeks were used for the assessment of
neurogenesis. To assess the total amount of newborn cells in the
adult dentate gyrus, bromodesoxyuridin (BrdU) was administered
by intraperitoneal injection (ZT6) at 100 mg/kg body weight and
the mice (3 per genotype) were sacrificed 4 days later at ZT6. For
the diurnal evaluation of proliferation, mice received a single dose
of BrdU (100 mg/kg body weight) for 10 hour labeling. The
injection schedule was as follows: injection at ZT 1 and perfusion
at ZT 11 for light phase labeling; injection at ZT 13 and perfusion
at ZT 23 for dark phase labeling (4 mice per genotype and time
point). The tissue was fixed by cardiovascular perfusion, cryopre-
served and sections of 40 mm were cut using a cryostat. For
immunohistochemical detection of BrdU streptavidin-biotin de-
tection was chosen. Free-floating sections were incubated in 1 M
HCl on ice for 10 min, then in 2 M HCl at RT for 10 min and
finally in 2 M HCl at 37uC for 20 min. Incubation in 0.1 M boric
acid at pH 8.5 for 12 min was performed for neutralization.
Sections were blocked for 1 h in 10% FBS/0.1% Triton X-100/
16TBS at RT, followed by specific blocking of streptavidin and
biotin binding sites in the tissue (Streptavidin-Biotin blocking kit
Vector labs). Primary antibodies diluted in 1% FBS/0.1% Triton
X-100/16TBS were added to the sections and incubated
overnight at 4uC. Antibodies were Anti-DCX (abcam ab18723),
Anti-BrdU [BU1/75 (ICR1)] (abcam ab6326) and Anti-NeuN
(Millipore MAB377). Secondary antibodies were biotinylated Anti-
rat (Vector Laboratories BA9400), Anti-mouse Cy5 and Anti-
rabbit Cy3 (Jackson Immuno Research 715-605-150 and 711-165-
152) for 3 h at RT and subsequently Streptavidin-FITC conjugate
(Vector Laboratories SA5001) 2 h at RT. Mounted tissue sections
were analyzed with a confocal microscope (Leica TCS SP5).
Fluorescent images covering the DG region were taken with 406
magnification and Z-stack of 1.5 mm through the entire coronal
section with frame average 3. Images were processed with LAS AS
software from LEICA. To estimate the number of immunolabelled
BrdU+ cells in the dentate gyrus (DG), systematic random
sampling of every sixth 40-mm coronal section along the rostro-
caudal axis of the DG (21.06 mm to 23.80 mm from bregma)
was chosen and performed according to [5]. Immunopositive cells
were counted and the total amount of cells per DG was calculated
by multiplying the results by six (because every sixth section had
been used).
Knockdown of Fabp7 by siRNA
SiRNA-mediated gene knockdown was achieved by using
Lipofectamine RNAiMAX transfection kit (Invitrogen). U-251
MG cells plated to 6-well plates and grown to 30-50% confluence
were transfected with 10 nM Stealth siRNA duplexes (Invitrogen):
FABP7HSS103516, FABP7HSS103517, FABP7HSS103518 and
siRNA negative control medium GC. Knockdown efficiency was
assessed 72 h post-transfection by western blotting and real-time
PCR.
SR8278 (REV-ERBa antagonist) treatment
25 mM SR8278 (Sigma) stock solution in DMSO was prepared.
Confluent cells were incubated during 24 h in presence of 10 mM
SR8278, if not otherwise stated. Equal volumes of DMSO were
used as control treatment.
Cell migration assay
Experiments were carried out with 24-well plates and polycar-
bonate Trans-well membrane inserts containing 8 mm pores
(Corning, 3422). 72 h after siRNA mediated gene knockdown
and 18 h after addition of 10 mM SR8278 (antagonist of REV-
ERBa) in DMSO (equal volumes of DMSO were used as control
treatment), U-251 MG cells were removed from the plate using
0.1% trypsin in 1xPBS and counted. 20’000 cells, in DMEM
without FCS, were plated to trans-well inserts and put in the
receiver-wells. DMEM containing 10% FCS in the receiver-well
was used as attractant. To allow migration, cells were incubated
for 6 h in a CO2 incubator. A Q-tip was used to remove non-
migrated cells from the upper side of the membrane, whereas
migrated cells on the lower side of the membrane were fixed and
stained for 10 min in 0.5% crystal violet/25% methanol. The
number of migrated cells was determined by counting them in
three random big squares of a Neubauer chamber and the results
were displayed as percent of migrated cells of the total amount of
cells plated per trans-well (3 mm2). Experiments were performed
in duplicates and repeated least three times. Representative
pictures of migrated cells were taken with a Zeiss Axioplan 2
microscope.
Proliferation study
The Luna automated cell counter (Logos Biosystems) was used
to assess proliferation of U-251 MG cells. Experiments were
carried out 72 h post transfection and 18 h after treatment with
10 mM SR8278. Cells were detached using 0.1% trypsin in 1xPBS
(2 min at 37uC), resuspended in growth medium and mixed with
an equal volume of trypan blue stain (0.4% in 1xPBS). 10 ml of
stained cell suspension was used per cell counting chamber,
samples were counted twice and experiments were performed four
times. Results were displayed as total cell number per well, since
the ratio of living and dead cells did not vary between samples.
Statistical analysis
Statistical evaluation of all experiments was performed using
GraphPad Prism4 software. Depending on the type of data, either
unpaired t-test, 1- or 2-way ANOVA with Bonferroni post-test was
performed. Values were considered significantly different with p,
0.05 (*), p,0.01 (**), or p,0.001 (***).
Results
Genome wide analysis reveals an increase of Fabp7 in the
SCN of Rev-erba KO mice
In order to detect differences in gene expression in brains of
wild- type versus Rev-erba KO mice we performed a microarray
analysis. We focused our analysis on the SCN, because REV-
ERBa is a component of the circadian clock of which the
pacemaker resides in the SCN [44]. In order to identify Rev-erba
regulated genes, we collected tissue 2 hours after the beginning of
the activity phase at zeitgeber time (ZT) 14, which is 2–4 hours
after maximal mRNA expression of Rev-erba [27]. Using Affimetrix
whole genome arrays we identified a number of differentially
expressed genes between the two genotypes (up-regulated genes
Table S1, down-regulated genes Table S2). The strongest
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differences in gene expression are summarized in Figure 1. The list
of up-regulated genes includes Bmal1 (Arntl) and Npas2, two clock
components that are directly regulated by REV-ERBa [27,45].
We focused on genes that were up-regulated in Rev-erba KO mice
(red, lower part in Fig. 1A), because REV-ERBa acts as a
repressor binding to RORE elements in the promoter of target
genes. Lack of Rev-erba will therefore lead to up-regulation of direct
target genes. Plotting the RMA (Robust Multi-array Analysis)
signals [37] from Rev-erba KO versus wild-type mice clearly
identified Fabp7 as the most up-regulated (4.5-fold) gene in the
SCN of Rev-erba KO animals (Fig. 1B).
Fabp7 is over-expressed in different brain regions of Rev-
erba KO mice
As a next step we verified the increased expression of Fabp7 in
Rev-erba KO mice using in situ hybridization, quantitative RT-
PCR (qRT-PCR) and further extended the validation at the
protein level by Western blotting. In situ hybridization experi-
ments performed on brain slices of wild-type, Per2Brdm1 mutant and
Rev-erba KO animals revealed increased expression of Fabp7
mRNA in Rev-erba KO mice. This expression was increased not
only in the SCN, but also throughout various brain regions,
including the hippocampus (HIP), the habenula (HB) (Figs. 2A and
S1) and the cortex (CX) (Fig. S1), which are known sites of Fabp7
expression [33]. In wild-type and Per2Brdm1 mutant mice, Fabp7
mRNA displayed a shallow diurnal pattern of expression (black
and red lines, respectively) in the SCN and HB, whereas in Rev-
erba KO animals, this expression was elevated at all time points
(green line, Fig. S1). More detailed analysis of the in situ
hybridization experiment revealed that in Rev-erba KO mice,
Fabp7 expression appeared to be elevated in the molecular layer
(Fig. 2B) and the SGZ of the hippocampus (arrows, Fig. 2B). Next
we quantified Fabp7 by qRT-PCR in hippocampus and found it to
be expressed in a phase consistent with the repression of its
expression by REV-ERBa (Fig. 2C). Similar to the increase in
mRNA expression of Fabp7 Western blot analysis on hippocampal
extracts from wild-type and Rev-erba KO mice revealed elevated
levels of FABP7 protein in the brain of Rev-erbaKOmice (Fig. 2D),
suggesting that Fabp7 is a target gene of REV-ERBa.
REV-ERBa regulates Fabp7 expression in vitro and in vivo
Expression analysis suggested that Fabp7 may be directly
regulated by REV-ERBa. To test this hypothesis we performed
transactivation experiments using a part of the Fabp7 promoter
fused to luciferase (Fabp7::luc) as a reporter and transfected this
construct into the neuroblastoma cell line NG108-15. We found
that REV-ERBarepressed the activity of the Fabp7 promoter in a
dose dependent manner comparable to the known REV-ERBa
mediated repression of the Bmal1 promoter (Fig. 3A). Deletion of
the proximal REV-ERBa binding element (RORE) on the Fabp7
promoter (2257 nt upstream of the transcription initiation site)
abolished REV-ERBa mediated repression (Fig. 3B). Interestingly,
the positive acting counterpart of REV-ERBa, the retinoic acid
related orphan receptor alpha (RORa), which also binds to
ROREs, activated the Fabp7 promoter in a similar fashion as it
activates Bmal1 (Fig. 3C). These results indicate that Fabp7 is
regulated by the nuclear receptors REV-ERBa and RORa. Since
these two nuclear receptors are components of the circadian clock,
we tested whether Fabp7 is activated in a time dependent fashion.
First, we verified that Fabp7 is regulated by a similar mechanism in
NIH 3T3 fibroblasts (Fig. S2). Thereafter, we monitored cyclic
expression of Fabp7::luc after synchronization of cells with
dexamethasone (Fig. 3D). Our experiments indicated a time
dependent regulation of the Fabp7 promoter in vitro in phase with
Bmal1.
In a next step, we tested whether REV-ERBa binds to the Fabp7
promoter in vivo by performing chromatin immunoprecipitation
(ChIP) using chromatin prepared from the hippocampal area.
Figure 1. Genome wide expression profiling of wild-type and Rev-erba2/2 tissue from suprachiasmatic nuclei (SCN). (A) The strongest
up- and down-regulated genes are displayed with red color marking the up-regulated genes and blue the down-regulated genes. The heat map is a
selection of genes from the array based on p,0.01 (t-test) and an absolute fold change greater than 1.75. The color code is based on the log2 value
of the fold change of the RMA values. The three columns per genotype represent the individual experiments (n = 3). (B) Plot of the RMA signals from
wild-type versus Rev-erba2/2 SCN reveals Fabp7 as the most up-regulated gene in Rev-erba2/2 mice (dotted lines represent 2 fold changes).
doi:10.1371/journal.pone.0099883.g001
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Figure 2. Expression profile of Fabp7 mRNA and protein in brain tissue. (A) In situ hybridization on coronal brain sections of wild-type,
Per2Brdm1, and Rev-erba2/2 mice at ZT4. The sections in the left column contain the SCN, the sections in right column the hippocampus (HIP) and
habenula (HB). (B) The panel shows dark-field microscopy of the hippocampus (HIP) in the dentate gyrus region. Blue represents Hoechst-dye stained
cell nuclei and the yellow signal represents the hybridization signal detecting Fabp7 mRNA. (C) Quantification of Fabp7 mRNA in the hippocampus of
wild-type (black) and Rev-erba2/2 mice (green) over the period of 24 hours (left panel). The right panel depicts the Rev-erba mRNA in the
hippocampus of wild-type (black) and Rev-erba2/2 mice (green). 2-way ANOVA reveals a significant difference between wild-type and Rev-erba2/2
mice (n = 3, p,0.05, mean6 SEM). (D) The left panel shows a Western blot illustrating FABP7 protein levels in the hippocampus area of wild-type and
Rev-erba2/2 mice. The right panel illustrates the quantification of FABP7 signal. 2-way ANOVA reveals a significant difference between wild-type and
Rev-erba2/2 mice (n = 3, p,0.05, mean 6 SEM).
doi:10.1371/journal.pone.0099883.g002
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Figure 3. Molecular regulation of the Fabp7 promoter. (A) The top panel depicts the murine Fabp7 (mFabp7) promoter with its two REV-ERBa
response elements (ROREs). Transactivation experiments in NG108-15 neurobalstoma cells show a repression potential of REV-ERBa that is similar for
both the Bmal1::luc and Fabp7::luc reporter constructs (n = 3, *p,0.05, mean 6 SD). (B) Deletion of the RORE element 257 nucleotides upstream of
the transcription start site of Fabp7 (Fabp7DRORE) abolishes the repression by REV-ERBa (n = 3, *p,0.05, mean 6 SD). (C) RORa activates the
REV-ERBa and Adult Hippocampal Neurogenesis
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REV-ERBa bound to the Fabp7 promoter in a time dependent
fashion and this binding was absent in Rev-erba KO mice (Fig. 3E).
This suggests that our observations made in cell cultures most
likely also apply in vivo.
Rev-erba KO mice show alterations in mood-related
behaviors and hippocampus-dependent cognitive
performance
Next, we performed behavioral tests comparing wild-type and
Rev-erba KO mice. Fabp7 maps to a quantitative trait locus for a
schizophrenia endophenotype [46] and therefore we employed a
prepulse inhibition (PPI) test, which is used as a measure for
schizophrenia. However, we found no difference between wild-
type and Rev-erba KO mice (Fig. 4A), which overexpress Fabp7, in
contrast to animals lacking Fabp7, which displayed a reduced
response in the PPI test [46]. In order to test anxiety related
behavior we used the elevated O-maze test during the light phase.
Both genotypes spent the same amount of time in the open area
(Fig.4B, left panel) and also the number of entries into the open
area was similar (Fig. 4B, right panel), indicating no significant
differences in anxiety. Next, we performed despair-based behav-
ioral tests that detect differences in mood-related behavior such as
mania and depression. The two genotypes did not differ in their
behavior in the tail suspension test (TST) at ZT6 as well as at
ZT18 (Fig. 4C). The data are shown over 3 consecutive days to
illustrate no changes due to learning or adaptation. A more
sensitive mood-related behavioral test, the forced swim test (FST)
revealed a tendency of wild-type animals towards higher
immobility at ZT6 compared to ZT18 (Fig. 4D). This is consistent
with our previous observations [47]. Interestingly, Rev-erba KO
mice showed significantly reduced immobility compared to wild-
type animals at ZT6 (Fig. 4D), although the total locomotor
activity levels are similar to wild-type animals [27]. In the
literature reduced immobility is often associated with ‘mania-like’
behavior, however, it may also reflect a deficit in learning to adapt
to a hopeless situation [48,49]. Therefore, we tested both
genotypes in memory related tests. Spontaneous alterations in a
Y-maze are considered a test of short term or working memory.
Mice tend to avoid an arm they just have visited and alternate
their entries among the arms, so re-entry into an arm just visited
suggests memory impairment [50]. In the Y-maze task, Rev-erba
KO mice showed reduced spontaneous alterations between the
arms compared to wild-type animals (Fig. 4E), suggesting a deficit
in working and short-term memory. To assess long-term memory
we employed the spatial object recognition test (SOR), which relies
on the innate propensity of mice to explore their environment and
recall where objects are located [51]. After training the mice to
learn the position of objects, one object was moved 24 hours later.
Wild-type mice will recall the position of the nondisplaced object
(NDO) and the exploration of the displaced object (DO) will be
favored. During the training session neither wild-type nor the Rev-
erba KO animals showed a preference for either object, but Rev-
erba KO mice showed less preference for the DO than wild-type
mice when tested 24 hours later (Fig. 4F, left panel). However, it
appeared that Rev-erba KO animals were in general less
explorative than wild-type animals (Fig. 4F, right panel). The
SOR test suggests long-term memory deficits of Rev-erba KO mice
as previously observed [52]. Taken together the results indicate
that Rev-erba KO animals display impaired hippocampal functions
regarding mood-related behavior and memory. We do not know,
however, whether these two behavioral phenotypes are function-
ally related, since Rev-erba may be responsible for the regulation of
several transcriptional events in the brain as evidenced in
figure 1A. In addition to Fabp7 up-regulation many other genes
including the glucocorticoid receptor (Nr3c1) are down-regulated
in Rev-erba KO mice and therefore it is very likely that the
behavioral phenotypes are the result of changes in more than one
transcriptional network.
Neurogenesis and FABP7 protein expression are
increased in the dentate gyrus of Rev-erba KO mice
Neurogenesis-deficient mice exhibit increased immobility in the
FST thus indicating a direct role of adult neurogenesis in
depressive illness [53]. Therefore we hypothesized that Rev-erba
KO animals, which show decreased immobility in the FST
(Fig. 4D), may display increased neurogenesis.
To test this hypothesis we performed immunohistochemistry to
visualize the formation of neurons in the SGZ of the hippocampal
DG. We found that expression of doublecortin (Dcx), a marker for
immature neurons, is increased in the Rev-erba KO hippocampus
(Fig. 5A). Furthermore, an increased number of cells has divided in
Rev-erba KO animals, as evidenced by the cell-cycle dependent
incorporation of bromodeoxyuridine (BrdU) (Fig. 5B). Dcx
staining and BrdU staining partially overlapped (Fig. 5B, magni-
fication), consistent with the accepted model of neurogenesis [32].
In the molecular layer of the hippocampus a partial overlap in
expression was observed between FABP7 and GFAP (Fig. S3).
This is consistent with previous observations describing FABP7 as
a marker for a subpopulation of glial cells [54].
Since we observed increased Fabp7 mRNA expression in the
SGZ of Rev-erba KO mice (Fig. 2B) we investigated its expression
at the protein level. Similar to its mRNA expression, more FABP7
protein containing cells were observed in the SGZ of Rev-erba KO
mice (Fig. 5C). Its expression did not co-localize with Dcx,
indicating that FABP7 may be a marker of a subpopulation of
neuronal stem cells (NSCs, Type-2 and Type-3) and early
transitory amplifying cells (TAPs) before Dcx starts to be expressed
in neuroblasts [32]. Overall these results suggest a correlation
between neurogenesis, FABP7 and REV-ERBa function.
The diurnal pattern of hippocampal neurogenesis is lost
and constantly high in Rev-erba KO mice
Because REV-ERBa appears to be responsible for the diurnal
expression of the NPC marker Fabp7 (Fig. 2, 3), we tested whether
the known diurnal pattern of neurogenesis [23–26] is lost in
FABP7 overexpressing Rev-erba KO mice. In wild-type animals we
observed a time of day dependent BrdU incorporation into
newborn cells in the SGZ of the hippocampus with higher
incorporation during the dark phase (ZT13-23) as compared to the
light phase (ZT1-11) (Fig. 6A left panel, 6B). In contrast
incorporation of BrdU into newly formed cells of Rev-erba KO
was constantly high and did not show a diurnal pattern. This
observation correlates with the observed constant overexpression
of Fabp7 in Rev-erba KO animals, suggesting that Rev-erba is
involved in establishing the diurnal pattern of adult neurogenesis.
Fabp7::luc reporter in a similar fashion as the Bmal1::luc reporter (n = 3, *p,0.05, mean 6 SD). (D) Real-time monitoring of NIH 3T3 cells transfected
with the Bmal1::luc and Fabp7::luc reporters, respectively. (E) Chromatin immunoprecipitation (ChIP) reveals time of day dependent binding of REV-
ERBa on the Fabp7 promoter in hippocampal tissue (n = 4, ***p,0.001, mean6 SEM, one-way ANOVA). denotes background binding of REV-ERBa at
the unrelated Fgf21 promoter.
doi:10.1371/journal.pone.0099883.g003
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Migration and proliferation of glioblastoma cells are
modulated by Rev-erba and Fabp7 in vitro
Approximately 80% of dividing progenitors in the SGZ are
directed to the neuronal fate and develop into dentate granule
neurons. They migrate radially into the inner third of the granule
layer where they start to display the morphology of mature granule
neurons (reviewed in [55]). Hence, migration is part of adult
neurogenesis. In order to establish a functional link between
increased expression of FABP7 in Rev-erba KOmice and migration
of neuronal cells, we looked at the migration properties of FABP7
expressing U-251 MG glioblastoma cells [36] in a transwell
migration assay.
Migration of the cells through micropores from one compart-
ment to the other was observed if the latter contained 10% fetal
calf serum (FCS). In contrast, no migration was observed if it was
left serum-free (Fig. 7A, B). Addition of the REV-ERBa antagonist
Figure 4. Mood-related behavior and hippocampus-dependent cognitive performance is altered in Rev-erba2/2 mice. (A) Mice were
subjected to prepulse inhibition (PPI) during the light phase. Startle response after a prepulse at 68, 72, 76, 80 and 84 dB, followed by a pulse at
120 dB represented as percentage of PPI with 100% as the first absolute startle values. Wild-type and Rev-erba2/2mice display a comparable amount
of PPI, which is a measure related to schizophrenia (mean6 SEM, n = 6). (B) Mice were tested at ZT0-2 in the anxiety related elevated O-maze test and
no significant differences between the two genotypes were observed (mean 6 SEM, n = 12, 2-way ANOVA). (C) Mice were subjected to the tail
suspension test (TST) at ZT6 and ZT18. No differences between the genotypes could be observed (mean 6 SEM, n= 6, 2-way ANOVA). (D) Mice were
subjected to the forced swim test (FST) at ZT6 and ZT18 for 3 consecutive days. Rev-erba2/2 mice were significantly less immobile compared to wild-
type animals at ZT6 (mean 6 SEM, n = 10, ***p,0.001, 2-way ANOVA). (E) Short term spatial memory was assessed between ZT4-6 using the Y-maze
test (mean6 SEM, Student’s t-test, **p,0.01, n = 12). (F) Long term spatial memory was assessed between ZT4-6 using the spatial object recognition
test (SOR). The left panel shows the preference for the displaced object (DO) 6 SEM (2-way ANOVA, p,0.05, n = 10). The right panel shows the total
time exploring objects in general (mean 6 SEM, 2-way ANOVA, **p,0.01, ***p,0.001, n = 10).
doi:10.1371/journal.pone.0099883.g004
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Figure 5. Immunohistochemistry in the dentate gyrus (DG) of wild-type and Rev-erba2/2 mice at ZT6. (A) Cell nuclei stained with DAPI
are in blue and antibodies recognizing doublecortin (Dcx) are in red. Dcx expression is increased in the subgranular zone of Rev-erba2/2 mice
indicating the presence of more neuroblasts in these animals. Scale bar: 100 mm. (B) Left panel: Visualization of cell division using bromodeoxyuridine
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SR8278 [56] increased FABP7 expression (Fig. S3A) and
migration of the cells compared to the solvent control DMSO,
indicating that suppression of REV-ERBa had a positive influence
on the migration properties of U-251 MG glioblastoma cells
(Fig. 7A, B). Introduction of siRNA against Fabp7 into the cells
suppressed both FABP7 expression (Fig. S3B) and migration in the
absence and presence of SR8278, (Fig. 7A, B) further supporting
the notion that Rev-erba modulates migration via Fabp7.
Another hallmark of neurogenesis is cell proliferation. Therefore
we tested in the same glioblastoma cell line whether the REV-
ERBa antagonist SR8278 and siRNA against Fabp7 can affect
proliferation. 72 hours after transfection of control and Fabp7
siRNAs, respectively, we counted the number of cells that have
grown in presence or absence of SR8278. Suppression of REV-
ERBa by its antagonist SR8278 increased proliferation, whereas
down regulation of FABP7 by its siRNA decreased it (Fig. 7C).
These results were in agreement with our in vivo finding that lack
of Rev-erba in mice increased proliferation in the DG (Fig. 5B). This
indicates that our observations in U-251 MG glioblastoma cells are
likely to be applicable to the DG. Overall it appears that Rev-erba
and Fabp7 are involved in the regulation of proliferation and
migration during the process of neurogenesis.
Discussion
In this study we used genome wide profiling to compare gene
expression in the SCN of wild-type and Rev-erba KO mice. We
identified Fabp7 as a direct target gene of REV-ERBa. In situ
hybridization and immunohistochemistry revealed an increase in
FABP7 expression in Rev-erba KO mice in several brain regions
including the SGZ of the hippocampus, suggesting an involvement
of REV-ERBa and FABP7 in adult neurogenesis. In accordance
with this notion Rev-erba KO mice displayed constantly high
proliferation of cells over the day compared to wild-type mice,
which displayed a diurnal pattern of neurogenesis in the SGZ. In
addition, in vitro manipulation of REV-ERBa and FABP7
affected migration and proliferation properties of glioblastoma
cells.
Gene expression profiling of NSCs and their neuronal progeny
in adult hippocampal tissue revealed many genes to be involved in
neurogenesis [7]. Interestingly, this study indicated that in NSCs
Rev-erba (Nr1d1) is about 4 times up-regulated compared to
immature neurons expressing Dcx [7], suggesting an involvement
of Rev-erba in the early steps of adult neurogenesis. Among the
potential target genes of Rev-erba identified in our study (Fig. 1,
Table S1), Fabp7 was found to affect neuronal differentiation [57].
However, because Fabp7 levels are low in NSCs (type 1) and
absent in Dcx expressing immature neurons (Fig. 5C, [32]) the
study by Bracko et al. [7] did not identify Fabp7 to be differentially
expressed between NSCs and immature neurons.
Analysis of Fabp7 over 24 hours revealed a diurnal expression of
its mRNA in brain tissue which is comparable to a previous study
[33] with a trough of expression around ZT16 that is almost anti-
phasic to the expression of Rev-erba (Fig. 2C). Although FABP7
protein levels do not fluctuate over time, lack of Rev-erba
significantly increased FABP7 protein levels in the brain
(Fig. 2D). Our transactivation and ChIP studies indicate that
REV-ERBa is a regulator of Fabp7 mRNA expression (Fig. 3).
Thus FABP7 appears to be one of the mediators of REV-ERBa
function in the brain.
Lack of Fabp7 in mice leads to altered emotional behavioral
responses [54] and has been associated with a schizophrenia
endophenotype [46]. In particular, Fabp7 KO mice exhibited a
differential response in the PPI test accompanied by reduced
proliferation in the SGZ [46]. In Rev-erba KO mice, which
overexpress Fabp7 (Fig. 2), the opposite phenotype with increased
proliferation in the SGZ (Fig. 5B, 6) and no change in the PPI test
(Fig. 4A) was observed. Similarly, anxiety related behavior is
(BrdU). Antibodies recognizing NeuN in blue mark nuclei of mature neurons, antibodies recognizing Dcx are in red and antibodies against BrdU are in
green. Scale bar: 50 mm. Right panel: Quantification of the BrdU+ cells after 4 days. Rev-erba2/2 mice display more BrdU positive cells (mean 6 SEM,
n = 3, **p,0.005, t-test). (C) FABP7 protein expression (green) does not overlap with Dcx protein expression and both expression levels are higher in
Rev-erba2/2 mice. The orthogonal sectioning to the right and at the bottom show reconstructions from a confocal z-stack in xz and yz direction,
respectively. The dotted white lines mark the granular layer of the DG. Scale bar: 50 mm.
doi:10.1371/journal.pone.0099883.g005
Figure 6. Neurogenesis in Rev-erba2/2 mice is constantly high and not diurnal. (A) BrdU was injected at ZT1 (upper panels) or ZT13 (lower
panels) and incorporation was assessed 10 hours later (ZT11 and ZT23, respectively) in wild-type (left panels) and Rev-erba2/2 KO (right panels).
Antibodies recognizing Dcx are in red and antibodies against BrdU are in green. The dotted white lines mark the granular layer of the DG. Scale bar:
50 mm. (B) Quantification of the BrdU+ cells after 10 hours. Rev-erba2/2 mice display more BrdU positive cells during the light phase (ZT1-11)
compared to wild-type (mean 6 SEM, n= 4, *p,0.05, 2-way ANOVA) whereas in the dark phase (ZT13-23) no difference in the number of BrdU
positive cells was observed between the genotypes.
doi:10.1371/journal.pone.0099883.g006
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altered in Fabp7 KO mice [54] but in the Fabp7 overexpressing
Rev-erba KO mice this is not the case (Fig. 4B). Furthermore, Rev-
erba KO animals did not differ in the tail suspension test (TST)
compared to wild-type, however, they responded differently to the
FST, spending less time immobile than their wild-type counter-
parts (Fig. 4D). Decreased immobility has been associated with
mania while increased immobility with depression [48] and
reduced neurogenesis [53]. Accordingly, one would expect an
increase of neurogenesis in Rev-erba KO mice. Our results support
this notion as more Dcx positive neuroblasts are observed in the
SGZ of Rev-erba KO animals (Fig. 5A). However, the effect of
REV-ERBa regulation via FABP7 appears to manifest before
neuroblasts are committed, as FABP7 expression did not co-
localize with Dcx positive cells (Fig. 5C). This is consistent with
previous observations describing a transitory expression of FABP7
in type 2 and 3 NSCs and early TAPs but not in late TAPs and
Dcx positive neuroblasts in the SVZ [32].
Adult neurogenesis in the hippocampus has also been associated
with learning and memory (for review see [55,58]). The short-term
memory and long-term memory tests we applied to the Rev-erba
KO mice revealed, that these animals had a deficit in the process
of memory formation (Fig. 4E, F). An increase in adult
neurogenesis in the hippocampus, as observed in Rev-erba KO
animals would, however, predict an improvement of memory
formation. This contradiction may be rooted in the multiple
functions of Rev-erba. Our microarray analysis (Fig. 1, Tables S1
and S2) clearly shows that many genes are altered in their
expression in Rev-erba KO mice. Of special interest in this context
is the down-regulation of the nuclear glucocorticoid receptor
(Nr3c1), because decreased signaling of this receptor in the
hippocampus impaired spatial memory in rats [59,60]. Interest-
ingly, a recent study shows that adult hippocampal neurogenesis
regulates forgetting indicating that too much neurogenesis may
jeopardize memory retention [61]. This notion correlates with our
findings.
The challenge for NSCs as for any other type of stem cells is to
keep the balance between proliferation and quiescence. This
balance is extremely important not only to keep a certain amount
of pluripotent NSCs in their niche, but also to avoid cancer
development due to over-proliferation. Niche signals, such as
notch signaling, can control dormant NSCs and push them
towards proliferative or keep them in a quiescent state [62]. Fabp7
may serve as a potential marker for mitotically activated NSCs in
the SVZ [32]. Rev-erba, as a repressor of Fabp7, may provide an
additional niche stimulus and therefore function as a brake to
avoid excessive proliferation of NSCs. This may explain why we
observe a strong increase in neurogenesis in the SGZ of Rev-erba
KO animals. If proliferation is constantly increased, gliomas may
develop, which are the most common primary malignancy in the
central nervous system of humans. In mice, however, gliomas are
hardly observed and we did not note development of gliomas in
Rev-erba KO mice. This may be due to compensation of increased
neurogenesis by elevation of cell death and/or apoptosis in Rev-
erba KO animal, which has been observed in the developing
cerebellum of these mice [63]. Alterations in cell death and
apoptosis in the adult hippocampus will have to be investigated in
Rev-erba KO mice in the future.
Glioblastoma tumors appear to contain cells with stem cell-like
properties, which contribute to invasion and chemoresistance
[64,65]. The stem cell-like cells grow as neurospheres in culture
and in comparison to adherent glioblastoma cells, they express
elevated levels of Fabp7 accompanied by elevated migration and
proliferation [57]. Manipulation of Rev-erba and Fabp7 in U-251
MG glioblastoma cells shows effects on migration and proliferation
(Fig. 7) that are in line with the observations described above.
Hence, it can be speculated that agonists for REV-ERBamay help
to reduce proliferation and migration in gliomas, which may
Figure 7. Influence of Rev-erba and Fabp7 on migration and
proliferation of U-251 MG glioblastoma cells. (A) Cells were
analyzed under non-migrating (0% FCS) and migrating (10% FCS)
conditions 6 hours after treatment. The Rev-erba antagonist SR8278
(10 mM) increased migration of the cells compared to DMSO control.
siRNA against Fabp7 (Fabp7 16) reduced this migration. Scale bar:
200 mm. (B) Quantification of the experiment in A. Shown is the mean
6 SD for n= 3 independent experiments (*p,0.05, **p,0.005, t-test).
(C) Number of cells 72 hours after transfection with either control or
Fabp7 siRNA in presence or absence of the Rev-erba antagonist SR 8278.
The mean 6 SD for n = 4 experiments (*p,0.05, **p,0.01, t-test) is
shown.
doi:10.1371/journal.pone.0099883.g007
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represent a novel avenue to combat this type of tumors in humans.
Interestingly, it appears that circadian genes are to some extent
related to glioma risk and outcome [66]. In particular elevated
levels of CLOCK contribute to cell proliferation and migration in
glioma [67]. Of note is that Clock is directly regulated by REV-
ERBa [45] and therefore agonists for REV-ERBa [4] may not
only reduce Fabp7 expression but also Clock levels, which may
reduce neurogenesis and lower the potential of glioblastoma
development.
Neurogenesis in the brain continuously declines with age [68].
This might be partially due to an increased quiescence of NSCs
and loss of Fabp7 expressing cells, as it has been observed in the
SVZ of aged mice [32]. Increasing Fabp7 by the application of
REV-ERBa antagonists may awake potentially dormant NSCs in
neurogenic pools and they may replenish dying cells. Hence,
REV-ERBa antagonists may improve the performance of the
ageing brain and help in the treatment of neurodegenerative
diseases such as Alzheimer disease [58].
Furthermore, antagonists for REV-ERBa may serve as anti-
depressants by increasing proliferation and migration (Fig. 7)
leading to a reduction of depressive symptoms (Fig. 4D). However,
future experiments will show to what extent the above predictions
can be met.
Overall our study shows that Rev-erba regulates Fabp7 and that
both genes appear to be involved in the modulation of
neurogenesis. This finding has far reaching implications, as
pharmacological targeting of Rev-erba may lead to improved
treatments for gliomas as well as neurological and depressive
disorders.
Supporting Information
Figure S1 Expression profile of Fabp7 mRNA and protein in
brain tissue. (A) Dark-field microscopy of the SCN and the
habenula (HB) comparing wild-type and Rev-erba2/2 mice at ZT4
and ZT16. The yellow signal represents the hybridization signal
detecting Fabp7 mRNA and blue represents Hoechst-dye stained
cell nuclei. (B) Quantification of the signal in the SCN, the HB and
cortex (CX) over time: black line = wild-type, red line =
Per2Brdm1, green line = Rev-erba2/2. The signal at ZT4 is double
plotted. The values comparing wild-type (or Per2Brdm1) with Rev-
erba2/2 are significantly different (n = 3, p,0.05, 2-way ANOVA,
mean 6 SEM).
(TIF)
Figure S2 Inhibition of Fabp7 transcription by REV-ERBa in
NIH 3T3 fibroblasts. Transactivation experiments show a dose
dependent repression potential of REV-ERBa that is similar for
both the Bmal1::luc and Fabp7::luc reporter constructs (n = 3, *p,
0.05, mean 6 SD).
(TIF)
Figure S3 Immunohistochemistry in the dentate gyrus (DG) of
wild-type and Rev-erba2/2 mice at ZT6. Overlapping signals
(yellow) of FABP7 (green) with GFAP expressing cells (red). The
orthogonal sectioning to the right and on the bottom depict
reconstructions from a confocal z-stack in xz and yz direction to
confirm that the FABP7 signal cell belongs in fact to the GFAP-
positive cell. Scale bar: 50 mm.
(TIF)
Figure S4 Immunobots showing efficiency of inhibition of REV-
ERBa activity and verification of siRNA knockdown of Fabp7 in
U-251 MG glioblastoma cells. (A) Quantification of FABP7 and
BMAL1 protein expression after treatment for 24 h with different
concentrations of REV-ERBa antagonist SR8278. Actin was used
for normalization. (n = 3, *p,0.05, mean 6 SD, t-test). (B) Left
panel: Comparison of Fabp7 knock down efficiency between three
different siRNAs against Fabp7 (16, 17, 18) and negative control
siRNA. Efficiency was tested 72 h post transfection with siRNA
and actin was used for normalization control. The fold change of
FABP7 protein expression was calculated setting the control
siRNA to 1 (n= 4, **p,0.01, mean 6 SD, t-test). Right panel:
Quantification of Fabp7 expression 72 h after siRNA knock down
or 18 h after treatment with 10 mM REV-ERBa antagonist
SR8278 by qRT-PCR. The fold change of Fabp7 mRNA
expression was calculated setting the control siRNA or solvent
control, DMSO, to 1. Experimental conditions were the same as
used for migration and proliferation assays (n = 3, *p,0.05, **p,
0.01, ***p,0.001, mean 6 SD, t-test).
(TIF)
Table S1 List of genes up-regulated in Rev-erba KO SCN.
(PDF)
Table S2 List of genes down-regulated in Rev-erba KO SCN.
(PDF)
Table S3 List of oligonucleotides used in this study.
(PDF)
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